Monarch Partners Asset Management LLC decreased its position in Acadia Healthcare Co. (NASDAQ:ACHC) by 56.3% during the second quarter, Holdings Channel reports. The firm owned 164,485 shares of the company’s stock after selling 212,229 shares during the period. Monarch Partners Asset Management LLC’s holdings in Acadia Healthcare were worth $9,112,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Pennant Capital Management LLC purchased a new stake in Acadia Healthcare during the first quarter worth approximately $83,685,000. Legal & General Group Plc increased its stake in Acadia Healthcare by 64.5% in the first quarter. Legal & General Group Plc now owns 5,064 shares of the company’s stock worth $279,000 after buying an additional 1,986 shares in the last quarter. BlackRock Fund Advisors increased its stake in Acadia Healthcare by 16.6% in the first quarter. BlackRock Fund Advisors now owns 776,809 shares of the company’s stock worth $42,810,000 after buying an additional 110,692 shares in the last quarter. Bank of Montreal Can purchased a new stake in Acadia Healthcare during the second quarter worth approximately $14,020,000. Finally, Arrowgrass Capital Partners US LP purchased a new stake in Acadia Healthcare during the first quarter worth approximately $1,378,000.
Shares of Acadia Healthcare Co. (NASDAQ:ACHC) traded down 1.33% on Monday, reaching $48.89. The company’s stock had a trading volume of 740,798 shares. The company has a 50 day moving average price of $50.84 and a 200 day moving average price of $55.15. The company has a market cap of $4.27 billion, a P/E ratio of 26.12 and a beta of 0.86. Acadia Healthcare Co. has a 52-week low of $46.99 and a 52-week high of $74.77.
Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Friday, July 29th. The company reported $0.73 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.73. The firm had revenue of $756.50 million for the quarter, compared to analyst estimates of $752.57 million. Acadia Healthcare had a return on equity of 9.35% and a net margin of 6.44%. The business’s quarterly revenue was up 66.8% compared to the same quarter last year. During the same period last year, the company earned $0.57 EPS. On average, analysts anticipate that Acadia Healthcare Co. will post $2.63 earnings per share for the current fiscal year.
ACHC has been the topic of a number of research reports. Leerink Swann reissued a “buy” rating and issued a $80.00 price objective on shares of Acadia Healthcare in a research note on Sunday, August 28th. Jefferies Group reaffirmed a “buy” rating on shares of Acadia Healthcare in a research report on Sunday, July 17th. Zacks Investment Research raised Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Monday. JPMorgan Chase & Co. reaffirmed a “hold” rating and set a $61.00 target price on shares of Acadia Healthcare in a research report on Tuesday, September 27th. Finally, RBC Capital Markets reaffirmed an “outperform” rating and set a $78.00 target price (down from $86.00) on shares of Acadia Healthcare in a research report on Monday, August 1st. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $77.21.
In other news, Director Reeve B. Waud sold 1,360,977 shares of the stock in a transaction on Friday, September 16th. The stock was sold at an average price of $48.52, for a total value of $66,034,604.04. Following the transaction, the director now owns 55,673 shares of the company’s stock, valued at approximately $2,701,253.96. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, major shareholder Waud Capital Partners Iii, L.L sold 457,443 shares of the stock in a transaction on Friday, September 16th. The shares were sold at an average price of $48.39, for a total value of $22,135,666.77. The disclosure for this sale can be found here. 17.20% of the stock is owned by insiders.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico.
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Co. (NASDAQ:ACHC).
Receive News & Ratings for Acadia Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Co. and related companies with MarketBeat.com's FREE daily email newsletter.